
Your Protein Intake Matters. This Visual Guide Shows How Much You Actually Need
Your daily protein needs will vary based on factors like body weight and activity level. A general guideline from the recommended dietary allowance for protein is 0.36 grams per pound of body weight per day. You can use the US Department of Agriculture's calculator for a more tailored estimate.
If you have fitness goals and need help visualizing how much protein you need, this guide is your blueprint for 100 grams of protein across different diets. The protein amounts below are estimates based on specific products and their nutrition labels, so your figures may vary depending on the brand or preparation method. Each picture contains 100 grams of protein combined, not 100 grams per item. If you want to get better at hitting your daily protein goals, this visual guide can help.
What 100 grams of protein looks like for omnivores
Amanda Capritto/CNET
Eating 100 grams of protein per day should be pretty easy if you don't have any dietary restrictions. Here's what that would look like:
Two eggs (12 grams)
Snack cheese (5 grams)
Greek yogurt (15 grams)
Beef sausage (14 grams)
One can of tuna (27 grams)
½ cup of rolled oats (5 grams)
2 ounces of deli ham (10 grams)
1 ounce of mixed nuts (5 grams)
Two slices of rye bread (10 grams)
Everything pictured above comes to 103 grams, which puts you slightly over your daily target.
What 100 grams of animal protein looks like for carnivores
Amanda Capritto/CNET
As you can see, getting 100 grams of protein from animal products doesn't take much:
Four eggs (24 grams)
One can of tuna (27 grams)
Three beef meatballs (15 grams)
2 ounces of turkey bacon (10 grams)
3 ounces of turkey breast (24 grams)
This amounts to a perfect 100 grams of protein. If you ate all of this in a day, plus bread and other nonanimal products, you would surpass 100 grams of protein in a day.
What 100 grams of protein looks like for vegetarians
Amanda Capritto/CNET
For vegetarians, 100 grams of protein might look like this:
Four eggs (24 grams)
½ cup of rolled oats (5 grams)
Two snack cheeses (10 grams)
¼ cup of protein granola (10 grams)
A single-serve Greek yogurt (15 grams)
One tablespoon of hemp seeds (4 grams)
Two tablespoons of peanut butter (7 grams)
One scoop of plant-based protein powder (20 grams)
This comes out to 99 grams of protein, which is pretty close.
What 100 grams of protein looks like for vegans
Amanda Capritto/CNET
What you see isn't totally what you get with the amount of protein here:
1 ounce of nuts (5 grams)
½ cup of rolled oats (5 grams)
A protein granola bar (8 grams)
Two slices of rye bread (10 grams)
¼ cup of protein granola (10 grams)
One tablespoon of hemp seeds (4 grams)
Two tablespoons of chia seeds (10 grams)
Two tablespoons of peanut butter (7 grams)
One scoop of plant-based protein powder (20 grams)
This amounts to 79 grams of protein. If we double up on the mixed nuts, chia seeds and hemp seeds, this brings us to 93 grams of protein. You could add an extra tablespoon of peanut butter or eat a full cup of oats, instead of half a cup, to come closer to 100 grams.
This plate also excludes high-protein vegan meat substitutes, such as tofu, tempeh or plant-based meats like the Impossible Burger. Those food sources can make it easier to get 100 grams of protein for someone who eats a vegan diet.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 hours ago
- Yahoo
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers. A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1130215. The archived webcast will be available in the Investor Relations section of the Company's website. About SIGA SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world's most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. Our flagship product, TPOXX® (tecovirimat), is an antiviral medicine approved in the U.S. and Canada for the treatment of smallpox and authorized in Europe, the UK, and Japan for the treatment of smallpox, mpox (monkeypox), cowpox, and vaccinia complications. For more information about SIGA, visit Contacts:Suzanne Harnettsharnett@ and Investors Media Jennifer Drew-Bear, Edison GroupJdrew-bear@ Holly Stevens, CG Lifehstevens@
Yahoo
19 hours ago
- Yahoo
Sarepta shares rebound after shipments of gene therapy Elevidys resume in US
(Reuters) -Sarepta Therapeutics shares surged more than 30% before the bell on Tuesday, as analysts said the resumption of U.S. shipments for its muscular gene therapy partially removes financial headwinds and decreases the risk of market withdrawal. The company said on Monday it would resume shipments of Elevidys — approved in the U.S. to treat a rare condition called Duchenne muscular dystrophy — to patients who can walk. U.S. shipments to patients who cannot walk independently are still halted, following the death of two teenage boys earlier this year. These incidents brought heightened regulatory scrutiny to Sarepta in recent weeks, while the pause of shipments raised concerns about the future of Elevidys — the company's largest revenue generator. Sarepta's announcement followed the U.S. Food and Drug Administration's recommendation that the voluntary hold on shipments be removed after a probe showed the death of an 8-year-old boy in Brazil was not related to Elevidys. Wall Street analysts said the resumption of shipments would allow Sarepta to fulfill its near-term payments to partner Arrowhead and maintain access to its debt facilities. "The FDA's recommendation and the resumption of commercial treatment in the U.S. virtually eliminate the risk of Elevidys being formally withdrawn from the market," said William Blair analyst Sami Corwin. While the decision allows some patients to regain access to the treatment, analysts warned that patients and doctors could show hesitancy in light of the recent hit to reputation. "It remains to be seen how the news headlines regarding the patient deaths will affect commercial interest in the near term," Corwin said. Sarepta's partner Roche had also stopped Elevidys shipments in certain countries outside the U.S. Shares of Sarepta surged 36% to $18.85 in premarket trading. They have fallen more than 80% since the first Elevidys-related death was reported in March. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data


The Hill
19 hours ago
- The Hill
Ham salad products recalled due to possible listeria: USDA
Two popular ham salad products have been recalled due to possible listeria contamination in one of the ingredients, breadcrumbs, according to the U.S. Department of Agriculture's (USDA) Food Safety and Inspection Service. Newly Weds Foods announced it is recalling Reser's Fine Foods Ham Salad and Molly's Kitchen Ham Salad, the products in question. 'The problem was discovered when Reser's Fine Foods, Inc., a Topeka, Kansas, establishment, determined that they used FDA-regulated breadcrumb products subject to an FDA recall because the breadcrumbs may be contaminated with [listeria monocytogenes],' the agency said in a press release. It's just the latest recall announcement tied to Reser's Fine Foods products made with potentially tainted bread crumbs. Albertsons recently announced a pair of recalls linked to tuna salad products made with breadcrumbs. The states included in those announcements were Illinois, Indiana, Iowa, Texas, Arkansas, Louisiana and Oklahoma. Thus far, there have been no confirmed reports of anyone getting ill from consuming the products. Anybody who consumes food contaminated with listeria is at risk of listeriosis, a serious infection that affects older adults, people with weakened immune systems, pregnant women and their babies.